Form 4 for IMNM Immunome Inc.
Accepted 2025-03-25 00:00:00 ET · period of report 2025-03-24 · accession 0001415889-25-008918 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-25 | 2025-03-24 | IMNM | Tsai Philip | CTO | P - Purchase | $8.42 | +12.3K | 33.3K | +59% | +$103.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-24 | P | A | 12,300 | $8.42 | 33,300 | D | — | — |